HilleVax, Inc HLVX IPO will take place April, 29 on the NASDAQ exchange under the ticker HLVX.
The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on October 26, 2022.
See also: Benzinga IPO Calendar
About HilleVax, Inc
HilleVax is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines.
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: IPOsBZI-IPOPreview
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in